Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FermentalgXPAR:ALGAE -4.04%52 Days Payable is 153.88 as of Dec. 2025, which is 48% below its 10-year median of 296.95. GuruFocus rates XPAR:ALGAE with a GF Score™ of 52/100 and a GF Value™ of €0.69 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 702 Biotechnology companies, Fermentalg ranks better than 51.57% on this metric.
Fermentalg's average Accounts Payable for the
six
months ended in Dec. 2025 was €4.00 Mil. Fermentalg's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €4.74 Mil.
Hence, Fermentalg's Days Payable for the
six
months ended in Dec. 2025 was 153.88.
The historical rank and industry rank for Fermentalg's Days Payable or its related term are showing as below:
XPAR:ALGAE'
s Days Payable Range Over the Past 10 Years
Min: 86.16 Med: 296.95 Max: 6970.68
Current: 118.56
During the past 13 years, Fermentalg's highest Days Payable was 6970.68. The lowest was 86.16. And the median was 296.95.
XPAR:ALGAE's Days Payable is ranked better than 51.57% of 702
companies
in the Biotechnology industry
Industry Median: 113.1
vs XPAR:ALGAE: 118.56
Fermentalg's Days Payable
increased
from Dec. 2024 (90.03) to Dec. 2025 (153.88).
It may suggest that Fermentalgdelayed paying its suppliers.
Fermentalg Days Payable Related Terms
Fermentalg Days Payable Historical Data
* Premium members only.
The historical data trend for Fermentalg's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALGAE vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Fermentalg's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fermentalg Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Fermentalg's Days Payable distribution charts can be found below:
* The bar in red indicates where Fermentalg's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Fermentalg's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fermentalg (XPAR:ALGAE) has a Days Payable of 153.88 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fermentalg and its competitors. This is 48% below median its historical median of 296.95. Over the past decade, Fermentalg's Days Payable has ranged from 86.16 to 6,970.68. According to the industry distribution chart, Fermentalg ranks #340 out of 702 companies in the Biotechnology industry, placing it in the top 48.4%.
Is Fermentalg's Days Payable too high?
Fermentalg's current Days Payable of 153.88 is 48% below median its 10-year median of 296.95. Over the past 10 years, this metric has ranged from a low of 86.16 to a high of 6,970.68. The Biotechnology industry median Days Payable is 113.10. Fermentalg's value of 153.88 is 36.1% above this industry median. Based on the distribution chart, Fermentalg ranks #340 out of 702 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Fermentalg has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fermentalg's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Fermentalg ranks #340 out of 702 companies for Days Payable. This puts Fermentalg in the upper half of its industry. The industry median Days Payable is 113.10. Fermentalg's value of 153.88 is 36.1% above this benchmark. Historically, Fermentalg's own Days Payable has ranged from 86.16 to 6,970.68 over the past decade. While the company's 10-year median is 296.95 vs. the industry median of 113.10, Fermentalg has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fermentalg's current Days Payable of 153.88 is 36.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fermentalg and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fermentalg's current Days Payable is 153.88, which is 48% below median its own 10-year median of 296.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fermentalg stock overvalued right now?
Based on GuruFocus' analysis, Fermentalg (XPAR:ALGAE) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.69, compared to a current price of €0.50 — trading 27.7% below its estimated fair value. The current Days Payable is 153.88, which is 48% below median its 10-year median of 296.95 and 36.1% above the Biotechnology industry median of 113.10. Fermentalg's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Fermentalg (XPAR:ALGAE), the current Days Payable is 153.88 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fermentalg (XPAR:ALGAE) Overvalued in 2026?
Based on GuruFocus' analysis, Fermentalg stock appears to be undervalued.
The current stock price of €0.50 is trading 27.7% below its estimated GF Value™ of €0.69.
GuruFocus considers Fermentalg to be Modestly Undervalued.
Key valuation signals for XPAR:ALGAE:
Days Payable: 153.88 (48% below median its 10-year median of 296.95)
GF Value™: €0.69 vs. price of €0.50 (27.7% below fair value)
Industry Position: 36.1% above the Biotechnology median (#340 of 702)
No single metric tells the full story. See the XPAR:ALGAE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fermentalg SA is an industrial biotechnology company engaged in producing natural cooking oils, animal nutrition products and chemicals using micro-algae.
52GF Score
Get the complete analysis for XPAR:ALGAE
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALGAE has been successfully added to your 
